Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-006109-26Phase 4Completed
Phase 4 trial of insulin glargine, insulin detemir and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by IKFE. Primary endpoint: Postprandial intact proinsulin secretion. Started Nov 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-006109-26.